your comparing a chart from 2 years ago on what fundamentals?
- Market cap is 10 million and they have a 10 million dollar funding program.
- Directors and CEO will be investing Thursday at 7.5 cents
- CEO coming in with more shares 1 month before GLP results already tells you the success and it’s already de risked from Feb announcement
- phase 1 starts in next 3-4 months and this is the exact same time as the Walter Reed results which have been derisked significantly from 2010 pre clinical studies which gives us another a big cash injection from the US department of defence which is non dilutive to advance phase 2.
- peers on pre clinical work have all traded at 70-100 million market caps and we are now in the same position
Fundamentals and for a drug with 10 million market cap and 10 million in funding with a huge amount of news flow over next 1-3 months and into later this year is just plain stupid. Will rerate very quickly and your Downramping a company that has 10 million in funding when it should be more like its peers at a 70-100 million market cap your funny
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)